Treatment of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor: A preliminary report
- 1 January 1989
- journal article
- research article
- Published by Elsevier in American Journal Of Medicine
- Vol. 86 (2), 178-182
- https://doi.org/10.1016/0002-9343(89)90265-9
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Phase I study of granulocyte colony-stimulating factor in patients with transitional cell carcinoma of the urothelium.Journal of Clinical Investigation, 1988
- The Molecular Control of Blood Cell DevelopmentScience, 1987
- Management of myelodysplastic syndromesThe American Journal of Medicine, 1986
- Recombinant Human Granulocyte Colony-Stimulating Factor: Effects on Normal and Leukemic Myeloid CellsScience, 1986
- Molecular cloning and expression of cDNA for human granulocyte colony-stimulating factorNature, 1986
- Identification of the human analogue of a regulator that induces differentiation in murine leukaemic cellsNature, 1985
- Modulation of normal myelopoiesis invitro by retinoic acidBiochemical and Biophysical Research Communications, 1984
- Proposals for the classification of the myelodysplastic syndromesBritish Journal of Haematology, 1982
- Hydrophobic adsorption chromatography of colony-stimulating activities and erythroid-enhancing activity from the human monocyte-like cell line, GCTBlood, 1981
- Separation of functionally distinct human granulocyte-macrophage colony- stimulating factorsBlood, 1979